Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.62 +0.01 (+0.61%)
As of: Sep 30, 2026 · 10:21 AM EDT

Chemomab Therapeutics (CMMB) EV to EBITDA (2021 - 2023)

Updated

Chemomab Therapeutics' (CMMB) EV to EBITDA stood at 0.17 in FY2025, down 88.3% from 1.42 in FY2024.

Analysis

Chemomab Therapeutics (CMMB) EV to EBITDA (2021 - 2023) Analysis & Trends

Starting with FY2021, Chemomab Therapeutics' EV to EBITDA history includes 5 years.

  • Annual EV to EBITDA has ranged from -0.79 in FY2023 to 5.03 in FY2021 over the past five years.
  • Per Business Quant data, CMMB's EV to EBITDA was 1.42 in FY2024, -0.79 in FY2023, -0.16 in FY2022 and 5.03 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.77
Sep 30, 2023 -0.39
Jun 30, 2023 -0.35
Mar 31, 2023 -0.07
Dec 31, 2022 -0.25
Sep 30, 2022 0.59
Jun 30, 2022 1.69
Mar 31, 2022 4.49
Dec 31, 2021 12.17
API Access

Chemomab Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CMMB&period=max&api_key=YOUR_API_KEY